Rice Hall James & Associates LLC Purchases Shares of 103,010 Simulations Plus, Inc. $SLP

Rice Hall James & Associates LLC acquired a new position in shares of Simulations Plus, Inc. (NASDAQ:SLP) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 103,010 shares of the technology company’s stock, valued at approximately $1,886,000. Rice Hall James & Associates LLC owned approximately 0.51% of Simulations Plus as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Royal Bank of Canada boosted its position in shares of Simulations Plus by 26.6% during the first quarter. Royal Bank of Canada now owns 114,885 shares of the technology company’s stock valued at $2,817,000 after buying an additional 24,132 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in Simulations Plus by 4.3% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,493 shares of the technology company’s stock worth $233,000 after buying an additional 390 shares in the last quarter. Dynamic Technology Lab Private Ltd purchased a new stake in Simulations Plus in the 1st quarter valued at $255,000. Woodline Partners LP lifted its stake in Simulations Plus by 32.1% during the 1st quarter. Woodline Partners LP now owns 13,239 shares of the technology company’s stock valued at $325,000 after acquiring an additional 3,220 shares in the last quarter. Finally, Rhumbline Advisers lifted its stake in Simulations Plus by 12.2% during the 2nd quarter. Rhumbline Advisers now owns 74,325 shares of the technology company’s stock valued at $1,297,000 after acquiring an additional 8,103 shares in the last quarter. 78.08% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Simulations Plus

In other news, Director Walter S. Woltosz sold 4,177 shares of the firm’s stock in a transaction that occurred on Wednesday, July 1st. The shares were sold at an average price of $18.44, for a total transaction of $77,023.88. Following the completion of the sale, the director owned 3,202,131 shares in the company, valued at $59,047,295.64. This trade represents a 0.13% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 19.10% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

SLP has been the topic of a number of analyst reports. Weiss Ratings raised shares of Simulations Plus from a “sell (d)” rating to a “sell (d+)” rating in a report on Friday, July 10th. William Blair downgraded shares of Simulations Plus from an “outperform” rating to a “market perform” rating in a report on Wednesday, June 17th. Craig Hallum lowered shares of Simulations Plus from a “buy” rating to a “hold” rating and set a $18.50 price target on the stock. in a research report on Thursday, June 18th. Finally, Wall Street Zen cut shares of Simulations Plus from a “buy” rating to a “hold” rating in a report on Saturday, June 13th. Seven analysts have rated the stock with a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Simulations Plus has a consensus rating of “Reduce” and a consensus price target of $17.25.

Simulations Plus Stock Performance

Shares of NASDAQ:SLP opened at $18.36 on Wednesday. The company’s 50-day moving average is $18.12 and its 200 day moving average is $15.26. The company has a market capitalization of $371.33 million, a P/E ratio of 45.90 and a beta of 1.32. Simulations Plus, Inc. has a fifty-two week low of $11.09 and a fifty-two week high of $21.01.

Simulations Plus (NASDAQ:SLP) last posted its quarterly earnings data on Thursday, July 9th. The technology company reported $0.30 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.23 by $0.07. The business had revenue of $21.89 million during the quarter, compared to the consensus estimate of $20.90 million. Simulations Plus had a net margin of 9.88% and a return on equity of 13.50%.

Simulations Plus Profile

Simulations Plus, Inc (NASDAQ: SLP) specializes in advanced modeling and simulation software tailored to the pharmaceutical, biotechnology and chemical industries. The company’s flagship products include ADMET Predictor, a quantitative structure-activity relationship (QSAR) tool for predicting absorption, distribution, metabolism, excretion and toxicity properties, and GastroPlus, a physiologically based pharmacokinetic (PBPK) modeling platform for simulating drug absorption and pharmacokinetics.